Overview

Daudi


Show Summary Details

Quick Reference

A well-characterized and established B lymphoblast cell line, derived in 1967 from a 16-year-old black male with Burkitt's lymphoma. The cells have surface complement receptors and IgG and are EBV marker positive, but negative for β2-microglobulin. They have been employed extensively in studies of mechanisms of leukaemogenesis.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.